{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,25]],"date-time":"2026-01-25T23:30:06Z","timestamp":1769383806659,"version":"3.49.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,12,10]],"date-time":"2020-12-10T00:00:00Z","timestamp":1607558400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81370535"],"award-info":[{"award-number":["81370535"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81570539"],"award-info":[{"award-number":["81570539"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81672701"],"award-info":[{"award-number":["81672701"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81802536"],"award-info":[{"award-number":["81802536"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002338","name":"Ministry of Education of the People&apos;s Republic of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002338","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013050","name":"Guangdong Provincial Applied Science and Technology Research and Development Program","doi-asserted-by":"publisher","award":["2016B020237004"],"award-info":[{"award-number":["2016B020237004"]}],"id":[{"id":"10.13039\/501100013050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010256","name":"Guangzhou Municipal Science and Technology Project","doi-asserted-by":"publisher","award":["1561000155"],"award-info":[{"award-number":["1561000155"]}],"id":[{"id":"10.13039\/501100010256","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","award":["19ykpy36"],"award-info":[{"award-number":["19ykpy36"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","award":["20ykpy22"],"award-info":[{"award-number":["20ykpy22"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012245","name":"Science and Technology Planning Project of Guangdong Province","doi-asserted-by":"publisher","award":["20160909"],"award-info":[{"award-number":["20160909"]}],"id":[{"id":"10.13039\/501100012245","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012245","name":"Science and Technology Planning Project of Guangdong Province","doi-asserted-by":"publisher","award":["2016A020215221"],"award-info":[{"award-number":["2016A020215221"]}],"id":[{"id":"10.13039\/501100012245","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012245","name":"Science and Technology Planning Project of Guangdong Province","doi-asserted-by":"publisher","award":["411308023039"],"award-info":[{"award-number":["411308023039"]}],"id":[{"id":"10.13039\/501100012245","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002402","name":"Sun Yat-sen University","doi-asserted-by":"publisher","award":["2020kfkt09"],"award-info":[{"award-number":["2020kfkt09"]}],"id":[{"id":"10.13039\/501100002402","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003453","name":"Natural Science Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2017A030313620"],"award-info":[{"award-number":["2017A030313620"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neoplasia"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.neo.2020.12.003","type":"journal-article","created":{"date-parts":[[2020,12,16]],"date-time":"2020-12-16T05:59:11Z","timestamp":1608098351000},"page":"158-168","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Suppression of CCDC6 sensitizes tumor to oncolytic virus M1"],"prefix":"10.1016","volume":"23","author":[{"given":"Ying","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ke","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen-bo","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen-tao","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin-cheng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuan","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Cai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guang-mei","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian-guang","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liang","family":"Peng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian-kai","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheng","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.neo.2020.12.003_bib0001","first-page":"1471","article-title":"Oncolysis of vascular malignant human melanoma tumors by Coxsackievirus A21","volume":"26","author":"Au","year":"2005","journal-title":"Int J Oncol"},{"key":"10.1016\/j.neo.2020.12.003_bib0002","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3005361","article-title":"Oncolytic and immunotherapeutic vaccinia induces antibody-mediated complement-dependent cancer cell lysis in humans","volume":"5","author":"Kim","year":"2013","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.neo.2020.12.003_bib0003","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1158\/1078-0432.CCR-10-1706","article-title":"Phase I clinical study of Seneca Valley Virus (SVV-001), a replication-competent picornavirus, in advanced solid tumors with neuroendocrine features","volume":"17","author":"Rudin","year":"2011","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.neo.2020.12.003_bib0004","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1038\/nbt.2287","article-title":"Oncolytic virotherapy","volume":"30","author":"Russell","year":"2012","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.neo.2020.12.003_bib0005","doi-asserted-by":"crossref","first-page":"3083","DOI":"10.2741\/2910","article-title":"Replication-competent retrovirus vectors for cancer gene therapy","volume":"13","author":"Tai","year":"2008","journal-title":"Front Biosci"},{"key":"10.1016\/j.neo.2020.12.003_bib0006","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1038\/sj.cdd.4401833","article-title":"Viruses, endoplasmic reticulum stress, and interferon responses","volume":"13","author":"He","year":"2006","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.neo.2020.12.003_bib0007","doi-asserted-by":"crossref","first-page":"3328","DOI":"10.4161\/cc.8.20.9832","article-title":"Alphavirus M1 induces apoptosis of malignant glioma cells via downregulation and nucleolar translocation of p21WAF1\/CIP1 protein","volume":"8","author":"Hu","year":"2009","journal-title":"Cell Cycle"},{"key":"10.1016\/j.neo.2020.12.003_bib0008","doi-asserted-by":"crossref","first-page":"E4504","DOI":"10.1073\/pnas.1408759111","article-title":"Identification and characterization of alphavirus M1 as a selective oncolytic virus targeting ZAP-defective human cancers","volume":"111","author":"Lin","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.neo.2020.12.003_bib0009","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/nature09907","article-title":"A diverse range of gene products are effectors of the type I interferon antiviral response","volume":"472","author":"Schoggins","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.neo.2020.12.003_bib0010","doi-asserted-by":"crossref","first-page":"eaam7996","DOI":"10.1126\/scitranslmed.aam7996","article-title":"Targeting VCP enhances anticancer activity of oncolytic virus M1 in hepatocellular carcinoma","volume":"9","author":"Zhang","year":"2017","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.neo.2020.12.003_bib0011","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/nrc.2016.14","article-title":"Antitumour actions of interferons: implications for cancer therapy","volume":"16","author":"Parker","year":"2016","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.neo.2020.12.003_bib0012","doi-asserted-by":"crossref","first-page":"71249","DOI":"10.18632\/oncotarget.19531","article-title":"Immunomodulatory and antitumor effects of type I interferons and their application in cancer therapy","volume":"8","author":"Medrano","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.neo.2020.12.003_bib0013","doi-asserted-by":"crossref","first-page":"322","DOI":"10.3389\/fonc.2018.00322","article-title":"Plasticity of type I interferon-mediated responses in cancer therapy: from anti-tumor immunity to resistance","volume":"8","author":"Budhwani","year":"2018","journal-title":"Front Oncol"},{"key":"10.1016\/j.neo.2020.12.003_bib0014","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/nri3845","article-title":"Type I interferons in anticancer immunity","volume":"15","author":"Zitvogel","year":"2015","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.neo.2020.12.003_bib0015","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.it.2017.05.005","article-title":"Type I interferon in chronic virus infection and cancer","volume":"38","author":"Snell","year":"2017","journal-title":"Trends Immunol"},{"key":"10.1016\/j.neo.2020.12.003_bib0016","doi-asserted-by":"crossref","first-page":"6167","DOI":"10.1038\/sj.onc.1210446","article-title":"Involvement of H4(D10S170) protein in ATM-dependent response to DNA damage","volume":"26","author":"Merolla","year":"2007","journal-title":"Oncogene"},{"key":"10.1016\/j.neo.2020.12.003_bib0017","doi-asserted-by":"crossref","first-page":"4257","DOI":"10.1016\/j.febslet.2012.10.029","article-title":"FBXW7-mediated degradation of CCDC6 is impaired by ATM during DNA damage response in lung cancer cells","volume":"586","author":"Jungang","year":"2012","journal-title":"FEBS Lett"},{"key":"10.1016\/j.neo.2020.12.003_bib0018","doi-asserted-by":"crossref","first-page":"e36177","DOI":"10.1371\/journal.pone.0036177","article-title":"Loss of CCDC6, the first identified RET partner gene, affects pH2AX S139 levels and accelerates mitotic entry upon DNA damage","volume":"7","author":"Merolla","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.neo.2020.12.003_bib0019","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.lungcan.2016.06.015","article-title":"USP7 inhibitors, downregulating CCDC6, sensitize lung neuroendocrine cancer cells to PARP-inhibitor drugs","volume":"107","author":"Malapelle","year":"2017","journal-title":"Lung Cancer"},{"key":"10.1016\/j.neo.2020.12.003_bib0020","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1002\/ijc.29263","article-title":"New therapeutic perspectives in CCDC6 deficient lung cancer cells","volume":"136","author":"Morra","year":"2015","journal-title":"Int J Cancer"},{"key":"10.1016\/j.neo.2020.12.003_bib0021","doi-asserted-by":"crossref","first-page":"4341","DOI":"10.1038\/onc.2010.179","article-title":"CCDC6 represses CREB1 activity by recruiting histone deacetylase 1 and protein phosphatase 1","volume":"29","author":"Leone","year":"2010","journal-title":"Oncogene"},{"key":"10.1016\/j.neo.2020.12.003_bib0022","doi-asserted-by":"crossref","first-page":"24694","DOI":"10.18632\/oncotarget.15788","article-title":"Interferon alpha antagonizes the anti-hepatoma activity of the oncolytic virus M1 by stimulating anti-viral immunity","volume":"8","author":"Ying","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.neo.2020.12.003_bib0023","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41419-018-0325-3","article-title":"Intravenous injections of the oncolytic virus M1 as a novel therapy for muscle-invasive bladder cancer article","volume":"9","author":"Hu","year":"2018","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.neo.2020.12.003_bib0024","doi-asserted-by":"crossref","first-page":"6812","DOI":"10.1073\/pnas.1701002114","article-title":"Selective replication of oncolytic virus M1 results in a bystander killing effect that is potentiated by Smac mimetics","volume":"114","author":"Cai","year":"2017","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.neo.2020.12.003_bib0025","first-page":"e01331","article-title":"Deficiency of the IRE1\u03b1-autophagy axis enhances the antitumor effects of the oncolytic virus M1","volume":"92","author":"Li","year":"2017","journal-title":"J Virol"},{"key":"10.1016\/j.neo.2020.12.003_bib0026","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1089\/hum.2017.055","article-title":"Selective antagonism of Bcl-xL potentiates M1 oncolysis by enhancing mitochondrial apoptosis","volume":"29","author":"Tan","year":"2018","journal-title":"Hum Gene Ther"},{"key":"10.1016\/j.neo.2020.12.003_bib0027","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-018-03913-6","article-title":"Inhibition of the mevalonate pathway enhances cancer cell oncolysis mediated by M1 virus","volume":"9","author":"Liang","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.neo.2020.12.003_bib0028","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1159\/000493285","article-title":"Association of low zinc finger antiviral protein expression with progression and poor survival of patients with hepatocellular carcinoma","volume":"49","author":"Liu","year":"2018","journal-title":"Cell Physiol Biochem"},{"key":"10.1016\/j.neo.2020.12.003_bib0029","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-018-06771-4","article-title":"DNA-PK inhibition synergizes with oncolytic virus M1 by inhibiting antiviral response and potentiating DNA damage","volume":"9","author":"Xiao","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.neo.2020.12.003_bib0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.micpath.2019.103919","article-title":"Web of interferon stimulated antiviral factors to control the influenza A viruses replication","volume":"139","author":"Goraya","year":"2020","journal-title":"Microb Pathog"},{"key":"10.1016\/j.neo.2020.12.003_bib0031","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/ncomms11320","article-title":"A human genome-wide loss-of-function screen identifies effective chikungunya antiviral drugs","volume":"7","author":"Karlas","year":"2016","journal-title":"Nat Commun"},{"key":"10.1016\/j.neo.2020.12.003_bib0032","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1002\/ijc.31106","article-title":"CCDC6: the identity of a protein known to be partner in fusion","volume":"142","author":"Cerrato","year":"2018","journal-title":"Int J Cancer"},{"key":"10.1016\/j.neo.2020.12.003_bib0033","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1038\/sj.embor.7400779","article-title":"Mediators of endoplasmic reticulum stress-induced apoptosis","volume":"7","author":"Szegezdi","year":"2006","journal-title":"EMBO Rep"},{"key":"10.1016\/j.neo.2020.12.003_bib0034","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.cytogfr.2010.04.001","article-title":"Oncolytic viruses as experimental treatments for malignant gliomas: using a scourge to treat a devil","volume":"21","author":"Zemp","year":"2010","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1016\/j.neo.2020.12.003_bib0035","doi-asserted-by":"crossref","first-page":"48443","DOI":"10.18632\/oncotarget.10305","article-title":"A classical PKA inhibitor increases the oncolytic effect of M1 virus via activation of exchange protein directly activated by cAMP 1","volume":"7","author":"Li","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.neo.2020.12.003_bib0036","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/mt.2015.172","article-title":"Activation of cyclic adenosine monophosphate pathway increases the sensitivity of cancer cells to the oncolytic Virus M1","volume":"24","author":"Li","year":"2016","journal-title":"Mol Ther"},{"key":"10.1016\/j.neo.2020.12.003_bib0037","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.canlet.2016.05.017","article-title":"Antitumor effect of FGFR inhibitors on a novel cholangiocarcinoma patient derived xenograft mouse model endogenously expressing an FGFR2-CCDC6 fusion protein","volume":"380","author":"Wang","year":"2016","journal-title":"Cancer Lett"},{"key":"10.1016\/j.neo.2020.12.003_bib0038","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1158\/2159-8290.CD-13-0050","article-title":"Identification of targetable FGFR gene fusions in diverse cancers","volume":"3","author":"Wu","year":"2013","journal-title":"Cancer Discov"},{"key":"10.1016\/j.neo.2020.12.003_bib0039","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1186\/s13046-016-0456-2","article-title":"Use of poly ADP-ribose polymerase [PARP] inhibitors in cancer cells bearing DDR defects: the rationale for their inclusion in the clinic","volume":"35","author":"Cerrato","year":"2016","journal-title":"J Exp Clin Cancer Res"},{"key":"10.1016\/j.neo.2020.12.003_bib0040","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1146\/annurev-med-050913-022545","article-title":"Synthetic lethality and cancer therapy: lessons learned from the development of PARP inhibitors","volume":"66","author":"Lord","year":"2015","journal-title":"Annu Rev Med"}],"container-title":["Neoplasia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1476558620301846?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1476558620301846?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T13:07:06Z","timestamp":1761484026000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1476558620301846"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["S1476558620301846"],"URL":"https:\/\/doi.org\/10.1016\/j.neo.2020.12.003","relation":{},"ISSN":["1476-5586"],"issn-type":[{"value":"1476-5586","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Suppression of CCDC6 sensitizes tumor to oncolytic virus M1","name":"articletitle","label":"Article Title"},{"value":"Neoplasia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neo.2020.12.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}